Tensegrity Pharma, Inc.
PrivateLast Round
Seed
Nov 13, 2024
Total Funding Raised
$4.15M
Company Overview
Tensegrity Pharma, Inc. is a biotechnology company that develops therapeutic candidates by reclaiming and advancing strategically discontinued drug projects for clinical validation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tensegrity Pharma, Inc. Comparables
Compare Tensegrity Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actimed Therapeutics | 82% | |
| Artelo Biosciences, Inc. | 71% | |
| Pfizer | 66% | |
Tensegrity Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 13, 2024 |
Tensegrity Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newton Biocapital | Seed |
| Mitsubishi UFJ Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 24, 2025
Grew 100% QoQ, from 4 to 8 employees.
- Oct 15, 2025
Grew 75% QoQ, from 4 to 7 employees.
Tensegrity Pharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tensegrity Pharma, Inc.'s valuation, stock price, and market status.